Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

147.10
+0.25000.17%
Pre-market: 147.100.00000.00%07:44 EDT
Volume:4.49M
Turnover:657.43M
Market Cap:182.50B
PE:-56.25
High:147.59
Open:146.73
Low:144.65
Close:146.85
52wk High:157.29
52wk Low:114.02
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.92
T/O Rate:0.36%
Dividend:3.22
Dividend Rate:2.19%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.43
PE(LYR):21.70

Loading ...

How Earnings Beat At Gilead Sciences Stock Has Changed Its Investment Story

Simply Wall St.
·
4 hours ago

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Yesterday

Moderna Inc. Stock Rises 4.8%, Outperforms Peers

Dow Jones
·
Yesterday

Gilead Sciences is Maintained at Overweight by JP Morgan

Dow Jones
·
Yesterday

Pharma Stocks Rally With Amgen, Gilead Sciences up 3%

Tiger Newspress
·
Oct 07

Early notable gainers among liquid option names on October 7th

TIPRANKS
·
Oct 07

JPMorgan Adjusts Price Target on Gilead Sciences to $170 From $160

MT Newswires Live
·
Oct 07

J.P. Morgan Remains a Buy on Gilead Sciences (GILD)

TIPRANKS
·
Oct 07

US Research Roundup-Allstate, Caribou Biosciences, Zscaler

Reuters
·
Oct 07

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Oct 07

Gilead : JP Morgan Raises Target Price to $170 from $160

THOMSON REUTERS
·
Oct 07

Moderna Inc. Stock Slips 7.8%, Underperforms Peers

Dow Jones
·
Oct 07

Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools

MT Newswires Live
·
Oct 06

Cognizant announces five-year extension of its work with Gilead Sciences

TIPRANKS
·
Oct 06

Cognizant - to Support Gilead's Devops and AI Tools Across Selected Technology Programs

THOMSON REUTERS
·
Oct 06

Cognizant Expands AI-Enabled Devops Capabilities for Gilead Sciences

THOMSON REUTERS
·
Oct 06

Entera Bio Appoints Ex-Gilead Executive Laura Hamill to Board of Directors

Reuters
·
Oct 06

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement
·
Oct 06

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Dow Jones
·
Oct 06

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Reuters
·
Oct 05